Hugh Gallagher

3.0k total citations
63 papers, 1.9k citations indexed

About

Hugh Gallagher is a scholar working on Nephrology, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Hugh Gallagher has authored 63 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Nephrology, 11 papers in Epidemiology and 11 papers in Economics and Econometrics. Recurrent topics in Hugh Gallagher's work include Chronic Kidney Disease and Diabetes (15 papers), Dialysis and Renal Disease Management (13 papers) and Chronic Disease Management Strategies (8 papers). Hugh Gallagher is often cited by papers focused on Chronic Kidney Disease and Diabetes (15 papers), Dialysis and Renal Disease Management (13 papers) and Chronic Disease Management Strategies (8 papers). Hugh Gallagher collaborates with scholars based in United Kingdom, Australia and United States. Hugh Gallagher's co-authors include Simon de Lusignan, Jeremy van Vlymen, Charles Tomson, Rebecca Suckling, Kevin Harris, Jonathan T.C. Kwan, David Jayne, Michael Adena, David P. Bryden and John B. Whitfield and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Kidney International.

In The Last Decade

Hugh Gallagher

61 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hugh Gallagher United Kingdom 24 712 330 278 241 232 63 1.9k
Aihua Bian United States 32 737 1.0× 351 1.1× 176 0.6× 287 1.2× 296 1.3× 86 2.8k
Chris Farmer United Kingdom 23 1.0k 1.4× 263 0.8× 277 1.0× 133 0.6× 168 0.7× 79 2.2k
Corinne S de Vries United Kingdom 25 442 0.6× 215 0.7× 176 0.6× 69 0.3× 275 1.2× 64 2.4k
Dong Chan Jin South Korea 26 959 1.3× 158 0.5× 256 0.9× 166 0.7× 173 0.7× 78 2.0k
Craig A. Solid United States 23 906 1.3× 259 0.8× 293 1.1× 194 0.8× 101 0.4× 71 2.2k
Amy Luke United States 25 522 0.7× 680 2.1× 349 1.3× 120 0.5× 438 1.9× 37 2.8k
Jiaxiao Shi United States 24 217 0.3× 261 0.8× 321 1.2× 145 0.6× 250 1.1× 101 2.3k
Arrigo Schieppati Italy 34 1.9k 2.7× 247 0.7× 905 3.3× 123 0.5× 326 1.4× 75 4.2k
Jing Fang China 19 1.0k 1.4× 492 1.5× 120 0.4× 115 0.5× 161 0.7× 35 2.2k
Óscar Zurriaga Spain 23 271 0.4× 239 0.7× 185 0.7× 321 1.3× 58 0.3× 98 1.7k

Countries citing papers authored by Hugh Gallagher

Since Specialization
Citations

This map shows the geographic impact of Hugh Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh Gallagher more than expected).

Fields of papers citing papers by Hugh Gallagher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugh Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh Gallagher. The network helps show where Hugh Gallagher may publish in the future.

Co-authorship network of co-authors of Hugh Gallagher

This figure shows the co-authorship network connecting the top 25 collaborators of Hugh Gallagher. A scholar is included among the top collaborators of Hugh Gallagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh Gallagher. Hugh Gallagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gallagher, Hugh, Shona Methven, Anna Casula, et al.. (2024). A stepped wedge cluster randomized trial of graphical surveillance of kidney function data to reduce late presentation for kidney replacement therapy. Kidney International. 106(3). 522–531.
2.
3.
Gallagher, Hugh, et al.. (2020). Chronic kidney disease in adults: assessment and management. Clinical Medicine. 20(2). 128–132. 88 indexed citations
4.
Cole, Nicholas, Harshana Liyanage, Rebecca Suckling, et al.. (2018). An ontological approach to identifying cases of chronic kidney disease from routine primary care data: a cross-sectional study. BMC Nephrology. 19(1). 85–85. 19 indexed citations
5.
Nihat, Akın, Simon de Lusignan, Nicola Thomas, Mohammad Tahir, & Hugh Gallagher. (2016). What drives quality improvement in chronic kidney disease (CKD) in primary care: process evaluation of the Quality Improvement in Chronic Kidney Disease (QICKD) trial. BMJ Open. 6(4). e008480–e008480. 13 indexed citations
6.
Lusignan, Simon de, Hugh Gallagher, Simon Jones, et al.. (2013). Audit-based education lowers systolic blood pressure in chronic kidney disease: the Quality Improvement in CKD (QICKD) trial results. Kidney International. 84(3). 609–620. 53 indexed citations
7.
McGovern, Andrew, Simon Jones, Harshana Liyanage, et al.. (2013). Association of chronic kidney disease (CKD) and failure to monitor renal function with adverse outcomes in people with diabetes: a primary care cohort study. BMC Nephrology. 14(1). 198–198. 18 indexed citations
8.
Lusignan, Simon de, Iain C. Macdougall, Hugh Gallagher, et al.. (2013). Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data. BMC Nephrology. 14(1). 24–24. 52 indexed citations
9.
McGovern, Andrew, Simon de Lusignan, Jeremy van Vlymen, et al.. (2013). Serum Phosphate as a Risk Factor for Cardiovascular Events in People with and without Chronic Kidney Disease: A Large Community Based Cohort Study. PLoS ONE. 8(9). e74996–e74996. 97 indexed citations
10.
Kearns, Benjamin, Hugh Gallagher, & Simon de Lusignan. (2013). Predicting the prevalence of chronic kidney disease in the English population: a cross-sectional study. BMC Nephrology. 14(1). 49–49. 28 indexed citations
11.
Lusignan, Simon de, Charles Tomson, Kevin Harris, Jeremy van Vlymen, & Hugh Gallagher. (2012). UK Prevalence of Chronic Kidney Disease for the Adult Population Is 6.76% Based on Two Creatinine Readings. Nephron Clinical Practice. 120(2). 11 indexed citations
12.
Lusignan, Simon de, Charles Tomson, Kevin Harris, Jeremy van Vlymen, & Hugh Gallagher. (2010). Creatinine Fluctuation Has a Greater Effect than the Formula to Estimate Glomerular Filtration Rate on the Prevalence of Chronic Kidney Disease. Nephron Clinical Practice. 117(3). c213–c224. 78 indexed citations
13.
Gallagher, Hugh, Simon de Lusignan, Kevin C. Harris, & Christopher J Cates. (2010). Quality-improvement strategies for the management of hypertension in chronic kidney disease in primary care: a systematic review. British Journal of General Practice. 60(575). e258–e265. 28 indexed citations
14.
Lusignan, Simon de, Kamlesh Khunti, Jonathan Belsey, et al.. (2009). A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data. Diabetic Medicine. 27(2). 203–209. 98 indexed citations
15.
Balasubramaniam, Gowrie, Edwina A. Brown, Andrew Davenport, et al.. (2009). The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrology Dialysis Transplantation. 24(10). 3209–3215. 107 indexed citations
16.
Lachmann, Helen J., Hugh J. B. Goodman, Peter Andrews, et al.. (2006). AA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: A report of two cases. Arthritis & Rheumatism. 54(6). 2010–2014. 36 indexed citations
17.
Gallagher, Hugh, Andrew V. Oleinikov, Christiane Fenske, & David Newman. (2004). The adaptor disabled-2 binds to the third ΨxNPxY sequence on the cytoplasmic tail of megalin. Biochimie. 86(3). 179–182. 25 indexed citations
18.
Gallagher, Hugh, Jonathan T.C. Kwan, & David Jayne. (2002). Pulmonary renal syndrome: A 4-year, single-center experience. American Journal of Kidney Diseases. 39(1). 42–47. 145 indexed citations
19.
Newman, David, Hansa Thakkar, & Hugh Gallagher. (2000). Progressive renal disease: does the quality of the proteinuria matter or only the quantity?. Clinica Chimica Acta. 297(1-2). 43–54. 17 indexed citations
20.
Gallagher, Hugh. (1996). The Politics of Polio.. Social Education. 60(5). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aihua Bian Breakdown of academic impact, for papers by Chris Farmer Breakdown of academic impact, for papers by Corinne S de Vries Breakdown of academic impact, for papers by Dong Chan Jin Breakdown of academic impact, for papers by Craig A. Solid Breakdown of academic impact, for papers by Amy Luke Breakdown of academic impact, for papers by Jiaxiao Shi Breakdown of academic impact, for papers by Arrigo Schieppati Breakdown of academic impact, for papers by Jing Fang Breakdown of academic impact, for papers by Óscar Zurriaga
Rankless by CCL
2026